Home > Cardiology > Endovascular baroreflex amplification appears safe, effective in resistant hypertension

Endovascular baroreflex amplification appears safe, effective in resistant hypertension


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 175
Journal
JACC: Cardiovascular Interventions
Reuters Health - 18/02/2022 - Endovascular baroreflex amplification (EVBA) with a stent-like device implanted in the carotid sinus appears safe and effective at reducing blood pressure over three years in patients with resistant hypertension, according to results of nonrandomized research. In the prospective, first-in-human study, published in JACC: Cardiovascular Interventions, Dr. Wilko Spiering of the Utrecht University, the Netherlands, and colleagues examined the long-term safety and efficacy of EVBA using the minimally invasive MobiusHD in 47 European and U.S. patients with resistant hypertension. The self-expandable nitinol device modifies the shape of "the carotid sinus and stretches the arterial wall without impairing its pulsatility," the authors explain. Patients in the U.S. and European CALM-FIM studies, lumped together for the current analysis, were between 18 and 80 years of age and had resistant hypertension characterized by an average office s...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on